Compare METC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | METC | ATRC |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2017 | 2005 |
| Metric | METC | ATRC |
|---|---|---|
| Price | $21.23 | $39.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $38.69 | ★ $52.22 |
| AVG Volume (30 Days) | ★ 2.6M | 464.6K |
| Earning Date | 03-09-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $579,503,000.00 | $518,304,999.00 |
| Revenue This Year | N/A | $16.94 |
| Revenue Next Year | $19.85 | $12.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $6.30 | $28.29 |
| 52 Week High | $57.80 | $43.18 |
| Indicator | METC | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 49.16 |
| Support Level | $20.08 | $36.06 |
| Resistance Level | $22.49 | $43.18 |
| Average True Range (ATR) | 1.54 | 1.95 |
| MACD | 0.48 | -0.33 |
| Stochastic Oscillator | 71.72 | 44.38 |
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.